Dai CY, Huang JF, Chuang WL, Yu ML. DAA Therapy in Hepatitis C in Patients With Chronic Kidney Disease: New Information for GFR Category G4 and G5. Clin Gastroenterol Hepatol 2022;20:246-7. [PMID: 33248105 DOI: 10.1016/j.cgh.2020.10.023][Reference Citation Analysis]
3
Kumada T, Toyoda H, Yasuda S, Tada T, Tanaka J, Chayama K, Johnson PJ, Irving WL. Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus. Infect Dis Ther 2021;10:1001-13. [PMID: 33881712 DOI: 10.1007/s40121-021-00441-7][Reference Citation Analysis]
4
Zhang W, Aryan M, Qian S, Cabrera R, Liu X. A Focused Review on Recent Advances in the Diagnosis and Treatment of Viral Hepatitis. Gastroenterology Res 2021;14:139-56. [PMID: 34267829 DOI: 10.14740/gr1405][Reference Citation Analysis]